bpc-157 safety human study Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review bpc-157 safety human studies review
Description
Heart rate elevated faster during cardio activities, with faster warm-up periods but reduced endurance
The medication is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN 2)
UV exposure degrades peptides
The peptide has demonstrated remarkable stability and has been shown to produce systemic effects even when administered at a single, distant site
